We contribute to society through state-of-the art non-clinical pharmacological research using our patented "STAM™ mice" technology
In order to develop new drugs, it is important to be able to accurately measure the effectiveness of drug candidates at a nonclinical trial stage.
Our "STAM™ mice" are disease model mice that more accurately reflect human pathology and therefore play a major role in pharmacology studies.
SERVICE
We support more than 600 pharmaceutical companies and bio-ventures in over 29 countries with our cutting-edge research and pharmacology studies.
SERVICE
Thanks to our extensive experience in various treatment fields, we are able to provide quick and decisive support for our client's pharmacological studies.
SERVICE
Our expert pathologists support the construction of experimental analysis systems, data acquisition and explanation of results, and maximize the information from the histology samples of pharmacology studies conducted by clients.
TRIAL
Clients are able to perform preliminary research using both blood samples and various other biospecimens from the disease model mice that SMC offer.
NEWS RELEASE
University of Nebraska’s publication on Biochemistry.
2019.09.09
SMC announced that University of Nebraska has published the results of a study using STAM™ model on Biochemistry.
NEWS RELEASE
Genomics Institute of the Novartis Research Foundation’s publication on Hepatology Communications.
2019.08.19
SMC announced that Genomics Institute of the Novartis Research Foundation has published the results of a study using STAM™ model on Hepatology Communications.
NEWS
FDA-National Center for Toxicological Research’s publication in Frontiers in Genetics.
2019.07.08
SMC announced that FDA-National Center for Toxicological Research (NCTR) published the results of a study using STAM™ model in Frontiers in Genetics.
